Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koki Shigenobu

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Cardiovascular Drug Reviews|June 19, 2002
Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channelsHikaru Tanaka, Koki Shigenobu
Journal of Pharmacological Sciences|November 19, 2005
Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug developmentHikaru Tanaka, Koki Shigenobu
Journal of Pharmacological Sciences|December 4, 2003
Optical bioimaging: from living tissue to a single molecule: atrio-ventricular difference in myocardial excitation-contraction coupling--sequential versus simultaneous activation of SR Ca2+ release unitsHikaru Tanaka, Toru Kawanishi, Koki Shigenobu
Journal of Pharmacological Sciences|August 2, 2003
Pharmacological evidence for involvement of phospholipase D, protein kinase C, and sodium-calcium exchanger in alpha-adrenoceptor-mediated negative inotropy in adult mouse ventricleKazuhide Nishimaru, Yoshio Tanaka, Hikaru Tanaka, et al.
Journal of Pharmacological Sciences|August 27, 2003
Inhibition of agonist-induced positive inotropy by a selective Rho-associated kinase inhibitor, Y-27632Kazuhide Nishimaru, Yoshio Tanaka, Hikaru Tanaka, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 20, 2004
[Molecular mechanisms for cAMP-independent activation of MaxiK channel: G protein direct channel regulation and contribution to the tuning of vascular smooth muscle tone]Fumiko Yamaki, Yoshio Tanaka, Takahiro Horinouchi, et al.
Biological & Pharmaceutical Bulletin|July 6, 2005
Comparison of the inhibitory effects of docosahexaenoic acid (DHA) on U46619- and phenylephrine-induced contractions in guinea-pig aortaKazuoki Otsuka, Yoshio Tanaka, Hikaru Tanaka, et al.
Journal of Pharmacological Sciences|April 11, 2003
Elucidation with the protease alpha-chymotrypsin of the inhibitory modulating action of endogenous neuropeptide Y over sympathetic neurotransmission in rat vas deferensKageyoshi Ono, Akira Saito, Katsutoshi Goto, et al.
European Journal of Pharmacology|July 18, 2006
Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overloadIyuki Namekata, Hideaki Shimada, Toru Kawanishi, et al.
Journal of Pharmacological Sciences|July 24, 2004
Effect of cilnidipine on L- and T-type calcium currents in guinea pig ventricle and action potential in rabbit sinoatrial nodeKentaro Takeda, Reiko Yamagishi, Haruko Masumiya, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cardiovascular Drug Reviews|June 19, 2002
Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channelsHikaru Tanaka, Koki Shigenobu
Journal of Pharmacological Sciences|November 19, 2005
Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug developmentHikaru Tanaka, Koki Shigenobu
Journal of Pharmacological Sciences|December 4, 2003
Optical bioimaging: from living tissue to a single molecule: atrio-ventricular difference in myocardial excitation-contraction coupling--sequential versus simultaneous activation of SR Ca2+ release unitsHikaru Tanaka, Toru Kawanishi, Koki Shigenobu
Journal of Pharmacological Sciences|August 2, 2003
Pharmacological evidence for involvement of phospholipase D, protein kinase C, and sodium-calcium exchanger in alpha-adrenoceptor-mediated negative inotropy in adult mouse ventricleKazuhide Nishimaru, Yoshio Tanaka, Hikaru Tanaka, et al.
Journal of Pharmacological Sciences|August 27, 2003
Inhibition of agonist-induced positive inotropy by a selective Rho-associated kinase inhibitor, Y-27632Kazuhide Nishimaru, Yoshio Tanaka, Hikaru Tanaka, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 20, 2004
[Molecular mechanisms for cAMP-independent activation of MaxiK channel: G protein direct channel regulation and contribution to the tuning of vascular smooth muscle tone]Fumiko Yamaki, Yoshio Tanaka, Takahiro Horinouchi, et al.
Biological & Pharmaceutical Bulletin|July 6, 2005
Comparison of the inhibitory effects of docosahexaenoic acid (DHA) on U46619- and phenylephrine-induced contractions in guinea-pig aortaKazuoki Otsuka, Yoshio Tanaka, Hikaru Tanaka, et al.
Journal of Pharmacological Sciences|April 11, 2003
Elucidation with the protease alpha-chymotrypsin of the inhibitory modulating action of endogenous neuropeptide Y over sympathetic neurotransmission in rat vas deferensKageyoshi Ono, Akira Saito, Katsutoshi Goto, et al.
European Journal of Pharmacology|July 18, 2006
Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overloadIyuki Namekata, Hideaki Shimada, Toru Kawanishi, et al.
Journal of Pharmacological Sciences|July 24, 2004
Effect of cilnidipine on L- and T-type calcium currents in guinea pig ventricle and action potential in rabbit sinoatrial nodeKentaro Takeda, Reiko Yamagishi, Haruko Masumiya, et al.
Pageof 5